Delivery Order SPE2DB22D3401-SPE2DB24FT1YB
Award Date
2/20/24
Potential Completion Date
2/21/24
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,416.30 firm fixed-price delivery order is for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract has an ultimate completion date of February 27, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,549.41 firm fixed-price contract is for the delivery of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract has a period of performance through July 22, 2022. This award is associated with AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, to support the agency's medical supply requirements. The award is a firm fixed-price delivery order with a ceiling value of $1,542.22 and a performance period through August 2, 2024. This contract is not set aside for any specific business category....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,646.80, is for the delivery of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract has a firm fixed price pricing type and an ultimate completion date of March 17, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $11,039.66, is for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The contract has a firm fixed price and is set to expire on July 9, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The firm-fixed-price delivery order, valued at $1,346.30, has a period of performance through September 16, 2024. This award is not associated with a set-aside program. As a leading supplier of medical products to the U.S. government, Amerisourcebergen has been...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,341.20, is a delivery order for ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine. The award has an ultimate completion date of December 30, 2024. This contract is not designated as a set-aside award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency, to Amerisourcebergen Drug Corp, a large pharmaceutical distributor. The $1,077.04 firm fixed-price contract is for the supply of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pediatric hepatitis B vaccine, to support federal healthcare programs. The award is not set-aside and has an ultimate completion date of July 25, 2024. Amerisourcebergen, through its Corporate Office division, has...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has a ceiling value of $1,782.82 and is a firm fixed price contract with a period of performance through July 2024. The contract is not set aside for any particular socioeconomic business category. AmerisourceBergen has been awarded multiple Indefinite Delivery...
This federal contract award, valued at $1,668.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of the ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML vaccine, with a completion date of December 18, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...